𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TNFα: kill or cure for demyelinating disease?

✍ Scribed by Finsen, B; Antel, J; Owens, T

Book ID
110059460
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
58 KB
Volume
7
Category
Article
ISSN
1359-4184

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TNFα downregulates PPARδ expression in o
TNFα downregulates PPARδ expression in oligodendrocyte progenitor cells: Implications for demyelinating diseases
✍ Annamaria Cimini; Antonietta Bernardo; Grazia Cifone; Luisa Di Muzio; Silvia Di 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

TNFalpha has been implicated in several demyelinating disorders, including multiple sclerosis (MS) and X-adrenoleukodystrophy (X-ALD). TNFalpha abundance is greatly increased in the areas surrounding damaged regions of the central nervous system of patients with MS and X-ALD, but its role in the obs

Liver diseases associated with anti-tumo
Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease
✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha